Moreover, breast cancer cells with high LDLR expression can affect the tumor immune microenvironment and lead to immunosuppression in the tumor microenvironment, which are high expression of immune checkpoints and reduced infiltration of immune killer cells. This evidence concerns the gene LDLR and breast cancer.